The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cytotherapy Market Research Report 2025
Synopsis
Cytotherapy is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
The global Cytotherapy market was valued at US$ 1543 million in 2023 and is anticipated to reach US$ 4915.9 million by 2030, witnessing a CAGR of 18.0% during the forecast period 2024-2030.
The cytotherapy market is driven by the increasing demand for regenerative medicine and cell-based therapies, offering potential treatments for a range of diseases and conditions. Stem cell therapies and other cell-based approaches hold promise for addressing previously untreatable conditions. However, a significant challenge in this market is the need for rigorous clinical trials and regulatory approvals to ensure the safety and efficacy of these therapies. Developing standardized protocols and navigating complex regulatory pathways can be time-consuming and costly. Additionally, the cost of cytotherapy treatments and access to these innovative therapies remain challenges, requiring healthcare systems and insurance providers to address affordability and accessibility issues.
This report aims to provide a comprehensive presentation of the global market for Cytotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cytotherapy.
Report Scope
The Cytotherapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cytotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cytotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Vcanbio
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Segment by Type
Stem Cell
Non-Stem Cell
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cytotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cytotherapy is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
The global Cytotherapy market was valued at US$ 1543 million in 2023 and is anticipated to reach US$ 4915.9 million by 2030, witnessing a CAGR of 18.0% during the forecast period 2024-2030.
The cytotherapy market is driven by the increasing demand for regenerative medicine and cell-based therapies, offering potential treatments for a range of diseases and conditions. Stem cell therapies and other cell-based approaches hold promise for addressing previously untreatable conditions. However, a significant challenge in this market is the need for rigorous clinical trials and regulatory approvals to ensure the safety and efficacy of these therapies. Developing standardized protocols and navigating complex regulatory pathways can be time-consuming and costly. Additionally, the cost of cytotherapy treatments and access to these innovative therapies remain challenges, requiring healthcare systems and insurance providers to address affordability and accessibility issues.
This report aims to provide a comprehensive presentation of the global market for Cytotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cytotherapy.
Report Scope
The Cytotherapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cytotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cytotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Vcanbio
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Segment by Type
Stem Cell
Non-Stem Cell
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cytotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cytotherapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Stem Cell
1.2.3 Non-Stem Cell
1.3 Market by Application
1.3.1 Global Cytotherapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cytotherapy Market Perspective (2019-2030)
2.2 Cytotherapy Growth Trends by Region
2.2.1 Global Cytotherapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cytotherapy Historic Market Size by Region (2019-2024)
2.2.3 Cytotherapy Forecasted Market Size by Region (2025-2030)
2.3 Cytotherapy Market Dynamics
2.3.1 Cytotherapy Industry Trends
2.3.2 Cytotherapy Market Drivers
2.3.3 Cytotherapy Market Challenges
2.3.4 Cytotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cytotherapy Players by Revenue
3.1.1 Global Top Cytotherapy Players by Revenue (2019-2024)
3.1.2 Global Cytotherapy Revenue Market Share by Players (2019-2024)
3.2 Global Cytotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cytotherapy Revenue
3.4 Global Cytotherapy Market Concentration Ratio
3.4.1 Global Cytotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cytotherapy Revenue in 2023
3.5 Cytotherapy Key Players Head office and Area Served
3.6 Key Players Cytotherapy Product Solution and Service
3.7 Date of Enter into Cytotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cytotherapy Breakdown Data by Type
4.1 Global Cytotherapy Historic Market Size by Type (2019-2024)
4.2 Global Cytotherapy Forecasted Market Size by Type (2025-2030)
5 Cytotherapy Breakdown Data by Application
5.1 Global Cytotherapy Historic Market Size by Application (2019-2024)
5.2 Global Cytotherapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cytotherapy Market Size (2019-2030)
6.2 North America Cytotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cytotherapy Market Size by Country (2019-2024)
6.4 North America Cytotherapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cytotherapy Market Size (2019-2030)
7.2 Europe Cytotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cytotherapy Market Size by Country (2019-2024)
7.4 Europe Cytotherapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cytotherapy Market Size (2019-2030)
8.2 Asia-Pacific Cytotherapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cytotherapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Cytotherapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cytotherapy Market Size (2019-2030)
9.2 Latin America Cytotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cytotherapy Market Size by Country (2019-2024)
9.4 Latin America Cytotherapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cytotherapy Market Size (2019-2030)
10.2 Middle East & Africa Cytotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cytotherapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Cytotherapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Detail
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Cytotherapy Introduction
11.1.4 Gilead Sciences Revenue in Cytotherapy Business (2019-2024)
11.1.5 Gilead Sciences Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Cytotherapy Introduction
11.2.4 Novartis Revenue in Cytotherapy Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Osiris
11.3.1 Osiris Company Detail
11.3.2 Osiris Business Overview
11.3.3 Osiris Cytotherapy Introduction
11.3.4 Osiris Revenue in Cytotherapy Business (2019-2024)
11.3.5 Osiris Recent Development
11.4 Vericel Corporation
11.4.1 Vericel Corporation Company Detail
11.4.2 Vericel Corporation Business Overview
11.4.3 Vericel Corporation Cytotherapy Introduction
11.4.4 Vericel Corporation Revenue in Cytotherapy Business (2019-2024)
11.4.5 Vericel Corporation Recent Development
11.5 Vcanbio
11.5.1 Vcanbio Company Detail
11.5.2 Vcanbio Business Overview
11.5.3 Vcanbio Cytotherapy Introduction
11.5.4 Vcanbio Revenue in Cytotherapy Business (2019-2024)
11.5.5 Vcanbio Recent Development
11.6 Fujifilm Cellular Dynamics
11.6.1 Fujifilm Cellular Dynamics Company Detail
11.6.2 Fujifilm Cellular Dynamics Business Overview
11.6.3 Fujifilm Cellular Dynamics Cytotherapy Introduction
11.6.4 Fujifilm Cellular Dynamics Revenue in Cytotherapy Business (2019-2024)
11.6.5 Fujifilm Cellular Dynamics Recent Development
11.7 JCR Pharmaceuticals
11.7.1 JCR Pharmaceuticals Company Detail
11.7.2 JCR Pharmaceuticals Business Overview
11.7.3 JCR Pharmaceuticals Cytotherapy Introduction
11.7.4 JCR Pharmaceuticals Revenue in Cytotherapy Business (2019-2024)
11.7.5 JCR Pharmaceuticals Recent Development
11.8 Beike Biotechnology
11.8.1 Beike Biotechnology Company Detail
11.8.2 Beike Biotechnology Business Overview
11.8.3 Beike Biotechnology Cytotherapy Introduction
11.8.4 Beike Biotechnology Revenue in Cytotherapy Business (2019-2024)
11.8.5 Beike Biotechnology Recent Development
11.9 Golden Meditech
11.9.1 Golden Meditech Company Detail
11.9.2 Golden Meditech Business Overview
11.9.3 Golden Meditech Cytotherapy Introduction
11.9.4 Golden Meditech Revenue in Cytotherapy Business (2019-2024)
11.9.5 Golden Meditech Recent Development
11.10 Guanhao Biotech
11.10.1 Guanhao Biotech Company Detail
11.10.2 Guanhao Biotech Business Overview
11.10.3 Guanhao Biotech Cytotherapy Introduction
11.10.4 Guanhao Biotech Revenue in Cytotherapy Business (2019-2024)
11.10.5 Guanhao Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
